The Therapeutic Synergy of Selinexor and Venetoclax in Mantle Cell Lymphoma Through Induction of DNA Damage and Perturbation of the DNA Damage Response

Introduction: Mantle cell lymphoma (MCL) can be stratified into blastoid and classical subtypes based on morphological features, with the former subtype having a poorer prognosis. Despite recent advances in targeted approaches, including multiple bruton tyrosine kinase inhibitors which yield impress...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Sheng, Zuo, Wei, Liu, Tingting, Fu, Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605683/
https://www.ncbi.nlm.nih.gov/pubmed/37880950
http://dx.doi.org/10.1177/15330338231208608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605683/
https://www.ncbi.nlm.nih.gov/pubmed/37880950
http://dx.doi.org/10.1177/15330338231208608

Ejemplares similares